Quick Answer
MUSTANG BIO, INC. reported Earnings Per Share Diluted of $0.39 (loss) per share for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +99.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $0.19 (loss) per share | Q2 2021: $0.16 (loss) per share | Q3 2021: $0.19 (loss) per share | Q1 2022: $2.71 (loss) per share | Q2 2022: $2.50 (loss) per share | Q3 2022: $2.42 (loss) per share | Q1 2023: $2.06 (loss) per share | Q2 2023: $2.00 (loss) per share | Q3 2023: $1.23 (loss) per share | Q1 2024: $24.81 (loss) per share | Q2 2024: $18.36 (loss) per share | Q3 2024: $1.96 (loss) per share | Q1 2025: $0.05 (loss) per share | Q2 2025: $0.19 (loss) per share | Q3 2025: $0.07 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), MUSTANG BIO, INC.'s Earnings Per Share Diluted has grown by 48.7%.
- Historical annual values: Fiscal year 2025: $0.39 (loss) per share | Fiscal year 2024: $38.57 (loss) per share | Fiscal year 2023: $299.95 (loss) per share | Fiscal year 2022: $10.09 (loss) per share | Fiscal year 2021: $0.76 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: